We have sought a novel mechanistic approach to understanding the key metabolic mechanism of RV failure by integrating metabolomic and epigenomic data using transcriptomics in failing RV and non-failing RVs using a mouse model of RV failure with BMPR2 mutation and correlating the findings with plasma from PAH patients. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.